https://www.selleckchem.com/pr....oducts/blasticidin-s
18.3% overall had recurrent AD, all of whom had confirmation on imaging. Computed tomography was used to calculate BMI in 849 patients, of whom 470 (55.4%) were considered obese (BMI 3. The likelihood of recurrent AD was not significantly different in obese patients compared to their non-obese counterparts (P = 0.2473). CONCLUSION While obesity increases the risk of developing AD overall, it does not appear to increase the likelihood of developing recurrent AD. This has implications for risk stratification when consideri